GOSH Conference 2020 - Our People • Our Patients • Our Hospital

4 Dec 2020, 10 a.m.

Our 4th annual GOSH conference was run virtually and delivered successfully by the GLA team on Friday, 20th November.

The themes of this year’s conference were Our patients, Our people and Our hospital.

GOSHConf_Themes

We had over 547 participants logged onto our conference. The day started with inspirational talk from GOSH’s YPF Governor Miss Grace Shaw-Hamilton, followed by RCPCH President, Prof. Russell Viner. The morning sessions went on to cover a broad width of topics around wellbeing, Culture Intelligence, Guarding our reputation, and much more. The day finished with ‘Green Hospital’, presented by Dr Nicholas Boyd, Consultant Anaesthetist, Bristol Children Hospital and Nick Martin, Sustainability Lead.

Congratulations to our Oral presentation winner Ms Helen Mercer and Digital poster winner Mr Dulanka Silva and their teams. We accepted a total 116 abstracts which represented a huge diversity of works have been done by our people and they will be published on the Archive of Childhood Disease.

Thank you all who have attended the conference and all the internal and external speakers who have made the day Informative and fabulous

GOSHConf_Keynote Speakers

‘Ready-made’ T-cell gene therapy tackles ‘incurable’ T-Cell leukaemia

A groundbreaking new treatment using gene-edited immune cells, developed at GOSH and UCL has shown promising results in helping children and adults fight a rare and aggressive cancer

NHS genetic testing gives ‘power’ to families with rare conditions

A new study has shown that whole genome sequencing, now offered as part of NHS care, allows children with rare conditions to access the right care faster.

GOSH Neonatal teams excelling in family-centred care

GOSH NICU has been awarded Bliss Baby Charter Silver Accreditation - a prestigious recognition of excellence in family-centred care.

GOSH manufactures new gene therapy for rare condition

A specialist laboratory team based at Great Ormond Street Hospital have manufactured a new gene therapy to treat a baby with the rare genetic condition, Hunter Syndrome.